Malaria vaccine: Phase III started

GlaxoSmithKline began a Phase III trial to evaluate RTS,S. The vaccine contains the QS-21 Stimulon adjuvant from Antigenics Inc. (NASDAQ:AGEN, New York, N.Y.), which GSK licensed rights to in 2006 (s...